Safety profile and clinical results of Remdesivir in Hemodialysis patients infected with SARS-CoV-2. A single-center Spanish cohort study

J Nephrol. 2023 Jan;36(1):171-172. doi: 10.1007/s40620-022-01364-3. Epub 2022 Jun 18.

Authors

Elena Cuadrado-Payán¹, Diana Rodríguez-Espinosa¹, José Jesús Broseta², Elena Guillén-Olmos¹, Francisco Maduell¹

Affiliations

¹ Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, Villarroel 170, 08036, Barcelona, Spain.
² Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, Villarroel 170, 08036, Barcelona, Spain. [email protected].

No abstract available

Keywords: COVID-19; COVID-19 treatment; Hemodialysis; Remdesivir; SARS-CoV-2.

Publication types

Letter

MeSH terms

Antiviral Agents / adverse effects
COVID-19 Drug Treatment
COVID-19*
Cohort Studies
Humans
Renal Dialysis / adverse effects
SARS-CoV-2*

Substances

remdesivir
Antiviral Agents